BackTable / Urology / Podcast / Episode #35

Diagnosis and Management of Upper Tract Urothelial Carcinoma

with Dr. Shahrokh Shariat

We talk with Dr. Shahrokh Shariat, chairman of Urology at the Medical University of Vienna, about diagnosis and management of upper tract urothelial carcinoma (UTUC) as well as differing AUA and EAU approaches to these malignancies.

Diagnosis and Management of Upper Tract Urothelial Carcinoma with Dr. Shahrokh Shariat on the BackTable Urology Podcast)
Ep 35 Diagnosis and Management of Upper Tract Urothelial Carcinoma with Dr. Shahrokh Shariat
00:00 / 01:04

BackTable, LLC (Producer). (2022, March 23). Ep. 35 – Diagnosis and Management of Upper Tract Urothelial Carcinoma [Audio podcast]. Retrieved from https://www.backtable.com

Earn CME

Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs.
Follow the button below to get started with CMEfy.

BackTable CMEfy button

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Shahrokh Shariat discusses Diagnosis and Management of Upper Tract Urothelial Carcinoma on the BackTable 35 Podcast

Dr. Shahrokh Shariat

Prof. Dr. Shariat heads the University Clinic for Urology at the Vienna General Hospital in Austria.

Dr. Aditya Bagrodia discusses Diagnosis and Management of Upper Tract Urothelial Carcinoma on the BackTable 35 Podcast

Dr. Aditya Bagrodia

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Show Notes

In this episode of BackTable Urology, Dr. Aditya Bagrodia and Dr. Shahrokh Shariat, chairman of Urology at the Medical University of Vienna, about diagnosis and management of upper tract urothelial carcinoma (UTUC) as well as differing AUA and EAU approaches to these malignancies.

First, the doctors discuss common history and physical examination findings of patients with UTUC. Hematuria is the the most common sign, followed by flank pain and hydronephrosis. 10-15% of UTUC patients will also have Lynch syndrome, which is a condition that indicates a genetic predisposition to UTUC as well as other cancers. After initial hematuria workup, imaging of the upper tract and kidney must be obtained. Dr. Shariat obtains a CT urogram and an ultrasound for patients with suspected UTUC but waits until a tumor is identified to get a chest X-ray. Indirect signs of UTUC are: filling defects, thickening of the ureter wall, and hydronephrosis.

Performing a ureteroscopy is the next step in UTUC patients. A ureteroscopy obtains adequate specimen for grading and reveals tumor behavior and location. A ureteroscopy can also be used as a therapeutic approach if kidney preservation is possible. Dr. Shariat uses a “no touch technique” in which he uses an access sheath to prevent tumor seeding. He prefers to use a flexible ureteroscope, a holmium laser, and a basket for collection. After ureteroscopy, he places a double J stent in his patients and waits for 6 weeks before taking a second look and starting alternating imaging, if needed.

Surgical intervention may be required to treat non-metastatic UTUC. Dr. Shariat usually administers four rounds of neoadjuvant chemotherapy to his patient before operating. He recommends checking the patient’s renal function to see if cisplatin-based therapy can be tolerated. Dr. Bagrodia and Dr. Shariat then compare the outcomes of cisplatin and carboplatin-based therapy.

Next, Dr. Shariat shares his tips for segmented ureterectomy. Although this procedure is relatively uncommon, he advocates for careful closure, intraoperative chemotherapy, and clipping the ureter above and below the tumor to prevent seeding.

To end the episode, the doctors discuss new UTUC therapeutic options, such as JELMYTO, a gel-based chemotherapy administered through a catheter. Finally, Dr. Shariat emphasizes once more that UTUC is a heterogenous cancer that requires multimodal therapy.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Earn CME When You Listen to BackTable CMEfy

Up Next

Radiotherapy for Unfavorable Intermediate Prostate Cancer with Dr. Neil Desai on the BackTable Urology Podcast)
Practical PSA Screening for PCPs and Urologists with Dr. Scott Eggener on the BackTable Urology Podcast)
Sugerencias y Mañas a la Hora de Ureteroscopia para Calculo Renal con Dr. Fernando Cabrera on the BackTable Urology Podcast)
Management of Penile Cancer with Dr. Philippe Spiess on the BackTable Urology Podcast)
Tips & Tricks for Difficult Ureteroscopy with Dr. Jodi Antonelli and Dr. Aditya Bagrodia on the BackTable Urology Podcast)
Minimally Invasive Focal Therapy for Prostate Cancer with Dr. Amit Patel and Dr. Ranko Miocinovic on the BackTable Urology Podcast)

Articles

Topics

Upper Tract Urothelial Carcinoma (UTUC) Condition Overview
Ureteral Stent Placement Procedure Prep
Ureterectomy Procedure Prep
Ureteroscopy Procedure Prep
Learn about Urologic Oncology on BackTable Urology

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.